Feedback / Questions
Pusintin (bevacizumab biosimilar) - TOT Biopharm
https://www.prnewswire.com/news-releases/tot-biopharm-announces-nmpa-granted-marketing-approval-for-pusintin-tab008-bevacizumab-injection-in-china-301434960.html
Dec 1, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next